Eli Lilly Offers Designers $75k to Redesign Clinical Trial Info for Patients

Eli Lilly opens Clinical Trial  Visualization Redesign Challenge for designers & developers to make clinical trial information more patient-friendly.

Eli Lilly, one of the world’s largest pharmaceutical companies, invites designers and developers to reimagine clinical trial  information in a patient-centric way. As part of Lilly’s Clinical Open Innovation initiative, which calls on open innovation to help transform clinical research and development, challenge participants are now being asked to focus on the ideas and possibilities for envisioning clinical trial protocols from a patient’s point of view.

Clinical trial information can often be dense and difficult to digest from a patient’s perspective. Patients may have questions surrounding the risks and benefits of their participation in the trial, logistics, the role of their personal doctor, and much more. The goal is to redesign that information so that key aspects are highlighted in a visually appealing and user-friendly way.

Submissions will take the form of design mockups and participants will be asked to submit one or more images, or browser viewable files, that incorporate key sections found in the Required Sections and Fields document and also use content data from the provided sample clinical trial documents.

Prizes totaling $75k will be awarded to the best mockups and redesigns including:

  • Grand prize -$35k
  • Second Prize – $20k
  • Third Prize – $10k
  • Honorable Mention (3) – $3k
  • Popular Choice – $1k
  • Large Organization Recognition Award – Non cash, recognition only

Submissions will be accepted until October 2, 2013.

Judging Criteria

  • Visual Presentation- includes visual appeal, and whether the hierarchy and density of information is user-friendly and digestible.
  • Patient Usefulness- includes whether the design highlights information valuable to patients and assists them in options for their next steps in health care.
  • Appropriateness for Mobile or Web Application- includes the potential to implement the design as a mobile or web app.
  • Potential Impact on Clinical Trials- includes the extent to which the submission may enrich the clinical trial experience for patients, caregivers, and medical institutions.

For more information and to register, visit http://ctdesign.challengepost.com/

Eli Lilly Offers Designers $75k to Redesign Clinical Trial Info for Patients by